FDA approves Biogen’s Alzheimer’s drug, Aduhelm June 7, 2021 Auto Bot Clinical Development 0 The US Food and Drug Administration (FDA) has approved Biogenâs Aduhelm (aducanumab) for the treatment of Alzheimerâs: making it the first new treatment approved for the disease since 2003.